怀孕期间部的过渡性骨质疏松症
Adam Morton1,2, Jennifer Savard-Heppel3
1Departments of Obstetric Medicine and Endocrinology, Mater Health, South Brisbane, Australia.
Obstetric medicine
|November 18, 2024
概括
关节的过渡性骨质疏松症,一种骨髓胀综合征,会影响孕妇和男性,导致关节疼痛和骨折风险. 需要进一步的研究来指导管理和了解复发风险.
科学领域:
- 整形外科 整形外科 整形外科
- 放射学 放射学是一门学科.
- 产科 产科 产科 产科 产科
背景情况:
- 关节的过渡性骨质疏松症 (TOH) 是一种不常见的骨髓综合征.
- 它的病理生理学仍然在很大程度上是未知的.
- 它影响孕妇和中年男性,导致部疼痛和移动性问题.
研究的目的:
- 总结一下当前对关节暂时性骨质疏松症的理解.
- 突出诊断方法和临床特征.
- 确定管理方面的知识差距,骨折风险和结果,特别是在怀孕期间.
主要方法:
- 文献综述侧重于病例系列,病例报告和有限的病例控制研究.
- 磁共振成像 (MRI) 作为主要的诊断工具.
- 对临床表现,风险因素和结果的分析.
主要成果:
- TOH表现为部疼痛和运动能力下降,孕妇的骨折风险更高.
- 磁力共振成像对诊断至关重要.
- 管理,骨折风险,分娩方式,母乳养安全和复发的证据有限.
结论:
- 由于证据有限,关节的过渡性骨质疏松症需要进一步调查.
- 建议建立一个国际怀孕登记册,以解决有关孕妇TOH的关键未解答问题.
- 为了有效的患者管理和结果预测,需要更好的理解.
更多相关视频
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
2.5K
05:55Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
473
相关概念视频
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
Ovarian Cycle
1.0K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.0K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
